By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Piper Jaffray Healthcare Conference 11/21/2014 10:01:04 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Third Quarter 2014 Financial And Operating Results 11/5/2014 7:44:50 AM
OncoMed Pharmaceuticals, Inc. (OMED) Granted Anti-DLL4/Anti-VEGF Bispecific Antibody Patent In The U.S. 11/3/2014 7:50:40 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical And Preclinical Data At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics Meeting 10/30/2014 10:54:41 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Announce Financial Results For The Third Quarter 2014 On Tuesday, November 4, 2014, After Close Of U.S.-Based Financial Markets 10/29/2014 7:55:03 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/7/2014 7:53:52 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Selection Of First Small Molecule Product Candidate Targeting The Wnt Pathway Under Collaboration With Bayer Pharma AG 9/30/2014 7:57:24 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Encouraging Data From Clinical Trials Of Tarextumab (Anti-Notch2/3) In Pancreatic Cancer And Small Cell Lung Cancer At The ESMO 2014 Congress 9/29/2014 11:12:18 AM
12345678910...
//-->